Limitations of using pregnancy-associated alpha-2 glycoprotein as a tumour marker-Reference-Cited by-同舟云学术

Limitations of using pregnancy-associated alpha-2 glycoprotein as a tumour marker

Published:1982-04 Issue:4 Volume:18 Page:327-332
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Müller Thomas,Bowen Margaret,De Mello Jose,Pidcock Nicola B.,Cooper Edward H.

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. An immunologic characteristic of the serum of normal pregnancy;MacLaren;Am J Obstet Gynecol,1959

2. Immunochemical determination of human pregnancy proteins;Bohn;Arch Gynaekol,1974

3. Pregnancy-associated alpha-2-glycoprotein levels in pregnancy, oral contraception and choriocarcinoma;Berne,1976

4. Dosage de la “pregnancy alpha 2 glycoprotein” dans le sérum de cancéreux prostatiques et évolution au cours du traitement oestrogénique;Lanson;J Urol Nephrol,1979

5. A critical comparison of the value of pregnancy-associated alpha-2-glycoprotein and CEA assays in patients with colorectal cancer;Wood;J Clin Pathol,1978

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era;Journal of Translational Medicine;2024-05-26

2. PREGNANCY ZONE PROTEIN - A REEVALUATION OF SERUM LEVELS IN HEALTHY WOMEN AND IN WOMEN SUFFERING FROM BREAST-CANCER OR TROPHOBLASTIC DISEASE;SCAND J CLIN LAB INV;1990

3. Pregnancy zone protein: a re-evaluation of serum levels in healthy women and in women suffering from breast cancer or trophoblastic disease;Scandinavian Journal of Clinical and Laboratory Investigation;1990-01

4. Biochemical Monitoring of Cancer;Clinical Biochemistry;1984